11-47343086-G-T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PM5PP3
The NM_000256.3(MYBPC3):c.1286C>A(p.Ala429Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A429V) has been classified as Pathogenic.
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.1286C>A | p.Ala429Glu | missense_variant | Exon 15 of 35 | 5 | NM_000256.3 | ENSP00000442795.1 | ||
MYBPC3 | ENST00000399249.6 | c.1286C>A | p.Ala429Glu | missense_variant | Exon 14 of 34 | 5 | ENSP00000382193.2 | |||
MYBPC3 | ENST00000544791.1 | n.1286C>A | non_coding_transcript_exon_variant | Exon 15 of 27 | 5 | ENSP00000444259.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Uncertain:1
This variant is denoted Ala429Glu (aka A429E) at the protein level and c.1286 C>A at the cDNA level. The Ala429Glu variant in the MYBPC3 gene has not been reported previously as a disease causing mutation nor as a benign polymorphism, to our knowledge. Ala429Glu results in a non conservative amino acid substitution of a non polar Alanine with a negatively charged Glutamic acid at a residue that is conserved across species. In addition, the Ala429Glu variant was not detected in up to 600 alleles from control individuals of Caucasian and African American ancestry, indicating it is not a common benign variant in these populations. However, data from ethnically matched controls is not available, therefore we cannot evaluate if Ala429Glu may be a population specific benign variant. In summary, with the clinical and molecular information available at this time, we cannot equivocally determine whether the Ala429Glu variant is a disease causing mutation or a rare benign variant. The variant is found in HCM panel(s). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at